We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Cardiovascular Diseases

News List

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study Biotech Newswire
August 28, 2024
Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.
Research Progress on the Pharmacological Effects of Salvianolic Acid B in Cardiovascular Diseases Xiaomichong
July 04, 2024
Sal B is a water-soluble component extracted from Danshen (Salvia miltiorrhiza). It is a phenolic acid compound formed by the condensation of 3 molecules of danshensu and 1 molecule of caffeic acid.
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company pharmafocusasia
December 24, 2018
Windtree Therapeutics, Inc., a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, and CVie Investments Limited (CVie).....